Altuncı, Y. A., Aydoğdu, M., Açıkgöz, E., Güven, Ü., Düzağaç, F., Atasoy, A., Dağlıoğlu, N., & Annette Akgür, S. (2021). New Psychoactive Substance 5-MeO-MiPT In vivo Acute Toxicity and Hystotoxicological Study. Balkan Med J, 38(1), 34-42.
Bäckberg, M., Westerbergh, J., Beck, O., & Helander, A. (2016). Adverse events related to the new psychoactive substance 3-fluorophenmetrazine – results from the Swedish STRIDA project. Clinical Toxicology, 54(9), 819-825.
Bengio, Y., Ducharme, R., Vincent, P., & Janvin, C. (2003). A neural probabilistic language model. J. Mach. Learn. Res., 3(null), 1137–1155.
Benowitz, N. L., Jacob Iii, P., Mayan, H., & Denaro, C. (1995). Sympathomimetic effects of paraxanthine and caffeine in humans. Clinical Pharmacology & Therapeutics, 58(6), 684-691.
Bersani, F. S., Corazza, O., Albano, G., Valeriani, G., Santacroce, R., Bolzan Mariotti Posocco, F., Cinosi, E., Simonato, P., Martinotti, G., Bersani, G., & Schifano, F. (2014). 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. BioMed research international, 2014, 734749.
Biesterbos, J. W. H., Sijm, D. T. H. M., van Dam, R., & Mol, H. G. J. (2019). A health risk for consumers: the presence of adulterated food supplements in the Netherlands. Food Additives & Contaminants: Part A, 36(9), 1273-1288.
Bouzembrak, Y., Steen, B., Neslo, R., Linge, J., Mojtahed, V., & Marvin, H. J. P. (2018). Development of food fraud media monitoring system based on text mining. Food Control, 93, 283-296.
Brandt, S. D., Walters, H. M., Partilla, J. S., Blough, B. E., Kavanagh, P. V., & Baumann, M. H. (2020). The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats. Psychopharmacology (Berl), 237(12), 3703-3714.
Carroll, B. C., McLaughlin, T. J., & Blake, D. R. (2006). Patterns and Knowledge of Nonmedical Use of Stimulants Among College Students. Archives of Pediatrics & Adolescent Medicine, 160(5), 481-485.
Chan, W. L., Wood, D. M., Hudson, S., & Dargan, P. I. (2013). Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. J Med Toxicol, 9(3), 278-281.
Chowdhary, K. R. (2020). Natural Language Processing. In K. R. Chowdhary (Ed.), Fundamentals of Artificial Intelligence (pp. 603-649). New Delhi: Springer India.
Cinosi, E., Corazza, O., Santacroce, R., Lupi, M., Acciavatti, T., Martinotti, G., & di Giannantonio, M. (2014). New drugs on the Internet: the case of Camfetamine. BioMed research international, 2014, 419026-419026.
Coffin, V. L., & Spealman, R. D. (1989). Psychomotor-stimulant effects of 3-isobutyl-1-methylxanthine: comparison with caffeine and 7-(2-chloroethyl) theophylline. Eur J Pharmacol, 170(1-2), 35-40.
Cohen, P. A., Travis, J. C., Keizers, P. H. J., Deuster, P., & Venhuis, B. J. (2018). Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clin Toxicol (Phila), 56(6), 421-426.
Corkery, J. M., Durkin, E., Elliott, S., Schifano, F., & Ghodse, A. H. (2012). The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): A brief review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 39(2), 259-262.
Corkery, J. M., Elliott, S., Schifano, F., Corazza, O., & Ghodse, A. H. (2012). 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review. Prog Neuropsychopharmacol Biol Psychiatry, 39(2), 253-258.
de Mello-Sampayo, C., Vaz, A. R., Henriques, S. C., Fernandes, A., Paradinha, F., Florindo, P., Faria, P., Moreira, R., Brites, D., & Lopes, A. (2021). Designer Cathinones N-Ethylhexedrone and Buphedrone Show Different In Vitro Neurotoxicity and Mice Behaviour Impairment. Neurotox Res, 39(2), 392-412.
Domagalska, E., Banaszkiewicz, L., Woźniak, M. K., Kata, M., Szpiech, B., & Kaliszan, M. (2020). Fatal N-Ethylhexedrone Intoxication. Journal of Analytical Toxicology.
ECD. (2020). WHO Expert Committee on Drug Dependence - TRS 1026 Forty-second report. In (pp. 44).
Fawzy, M., Wong-Morrow, W. S., Beaumont, A., & Farmer, C. K. T. (2017). Acute kidney injury and critical limb ischaemia associated with the use of the so called “legal high” 3-fluorophenmetrazine. CEN Case Reports, 6(2), 152-155.
Gatch, M. B., Dolan, S. B., & Forster, M. J. (2017). Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents. Behav Pharmacol, 28(5), 375-385.
Helle, C., Sommer, A. K., Syversen, P. V., & Lauritzen, F. (2019). Doping substances in dietary supplements. Tidsskr Nor Laegeforen, 139(4).
Hill, S. L., Doris, T., Gurung, S., Katebe, S., Lomas, A., Dunn, M., Blain, P., & Thomas, S. H. (2013). Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clin Toxicol (Phila), 51(6), 487-492.
INCB. (2020). Report of the International Narcotics Control Board for 2019. In. Vienne: UNITED NATIONS.
Joensuu, M., Tolmunen, T., Saarinen, P., Tiihonen, J., & Lehtonen, J. (2007). Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [123I] nor-²-CIT SPECT imaging. Psychiatry Research: Neuroimaging, 154, 125-131.
Katselou, M., Papoutsis, I., Nikolaou, P., Spiliopoulou, C., & Athanaselis, S. (2015). 5-(2-aminopropyl)indole: a new player in the drama of 'legal highs' alerts the community. Drug Alcohol Rev, 34(1), 51-57.
Kling-Petersen, T., Ljung, E., & Svensson, K. (1994). The preferential dopamine autoreceptor antagonist (+)-UH232 antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm. Pharmacology Biochemistry and Behavior, 49(2), 345-351.
Končić, M. (2018). Getting More Than You Paid For: Unauthorized "Natural" Substances in Herbal Food Supplements on EU Market. Planta Med, 84(6-07), 394-406.
Lajtai, A., Mayer, M., Lakatos, Á., Kuzma, M., & Miseta, A. (2020). New psychoactive versus conventional stimulants - a ten-year review of casework in Hungary. Legal Medicine, 47, 101780.
Logan, B. K., Goldfogel, G., Hamilton, R., & Kuhlman, J. (2009). Five deaths resulting from abuse of dextromethorphan sold over the internet. J Anal Toxicol, 33(2), 99-103.
Majchrzak, M., Celiński, R., Kuś, P., Kowalska, T., & Sajewicz, M. (2018). The newest cathinone derivatives as designer drugs: an analytical and toxicological review. Forensic Toxicol, 36(1), 33-50.
Manier, S. K., Felske, C., Eckstein, N., & Meyer, M. R. (2020). The metabolic fate of two new psychoactive substances − 2-aminoindane and N-methyl-2-aminoindane − studied in vitro and in vivo to support drug testing. Drug Testing and Analysis, 12(1), 145-151.
Martin, S. J., Sherley, M., & McLeod, M. (2018). Adverse effects of sports supplements in men. Australian prescriber, 41(1), 10-13.
Marusich, J. A., Antonazzo, K. R., Blough, B. E., Brandt, S. D., Kavanagh, P. V., Partilla, J. S., & Baumann, M. H. (2016). The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue. Neuropharmacology, 101, 68-75.
Marvin, H. J. P., Kleter, G. A., Frewer, L. J., Cope, S., Wentholt, M. T. A., & Rowe, G. (2009). A working procedure for identifying emerging food safety issues at an early stage: Implications for European and international risk management practices. Food Control, 20(4), 345-356.
Maskell, P. D., Smith, P. R., Cole, R., Hikin, L., & Morley, S. R. (2016). Seven fatalities associated with ethylphenidate. Forensic Sci Int, 265, 70-74.
Mayer, F. P., Burchardt, N. V., Decker, A. M., Partilla, J. S., Li, Y., McLaughlin, G., Kavanagh, P. V., Sandtner, W., Blough, B. E., Brandt, S. D., Baumann, M. H., & Sitte, H. H. (2018). Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 family. Neuropharmacology, 134(Pt A), 149-157.
Meijer, N., Filter, M., Józwiak, Á., Willems, D., Frewer, L., Fischer, A., Liu, N., Bouzembrak, Y., Valentin, L., Fuhrmann, M., Mylord, T., Kerekes, K., Farkas, Z., Hadjigeorgiou, E., Clark, B., Coles, D., Comber, R., Simpson, E., & Marvin, H. (2020). Determination and Metrics for Emerging Risks Identification DEMETER: Final Report. EFSA Supporting Publications, 17(7), 1889E.
Mestria, S., Odoardi, S., Federici, S., Bilel, S., Tirri, M., Marti, M., & Strano Rossi, S. (2020). Metabolism Study of N-Methyl 2-Aminoindane (NM2AI) and Determination of Metabolites in Biological Samples by LC–HRMS. Journal of Analytical Toxicology.
Mikolov, T., Corrado, G., Chen, K., & Dean, J. (2013). Efficient estimation of word representations in vector space. https://arxiv.org/abs/1301.3781.
Mikolov, T., Yih, W.-t., & Zweig, G. (2013). Linguistic Regularities in Continuous Space Word Representations. In Proceedings of the 2013 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies (pp. 746-751). Atlanta, Georgia: Association for Computational Linguistics.
Parks, C., McKeown, D., & Torrance, H. J. (2015). A review of ethylphenidate in deaths in east and west Scotland. Forensic Sci Int, 257, 203-208.
Pennington, J., Socher, R., & Manning, C. (2014). GloVe: Global Vectors for Word Representation. In Proceedings of the 2014 Conference on Empirical Methods in Natural Language Processing (EMNLP) (pp. 1532-1543). Doha, Qatar: Association for Computational Linguistics.
Reissig, C. J., Carter, L. P., Johnson, M. W., Mintzer, M. Z., Klinedinst, M. A., & Griffiths, R. R. (2012). High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology, 223(1), 1-15.
Repke, D. B., Grotjahn, D. B., & Shulgin, A. T. (1985). Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents. Journal of Medicinal Chemistry, 28(7), 892-896.
Richeval, C., Dumestre-Toulet, V., Wiart, J. F., Vanhoye, X., Humbert, L., Nachon-Phanithavong, M., Allorge, D., & Gaulier, J. M. (2019). New psychoactive substances in oral fluid of drivers around a music festival in south-west France in 2017. Forensic Sci Int, 297, 265-269.
Roque Bravo, R., Carmo, H., Silva, J. P., Valente, M. J., Carvalho, F., Bastos, M. d. L., & Dias da Silva, D. (2020). Emerging club drugs: 5-(2-aminopropyl)benzofuran (5-APB) is more toxic than its isomer 6-(2-aminopropyl)benzofuran (6-APB) in hepatocyte cellular models. Archives of Toxicology, 94(2), 609-629.
Rothman, R. B., Partilla, J. S., Baumann, M. H., Lightfoot-Siordia, C., & Blough, B. E. (2012). Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters. The Journal of pharmacology and experimental therapeutics, 341(1), 251-262.
Schwartz, A. R., Pizon, A. F., & Brooks, D. E. (2008). Dextromethorphan-induced serotonin syndrome. Clin Toxicol (Phila), 46(8), 771-773.
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020). New psychoactive substances: a review and updates. Therapeutic advances in psychopharmacology, 10, 2045125320967197-2045125320967197.
Smilkov, D., Thorat, N., Nicholson, C., Reif, E., Viégas, F. B., & Wattenberg, M. (2016). Embedding projector: Interactive visualization and interpretation of embeddings. . arXiv preprint arXiv:1611.05469.
Tolliver, B. K., & Carney, J. M. (1995). Locomotor stimulant effects of cocaine and novel cocaine analogs in DBA/2J and C57BL/6J inbred mice. Pharmacol Biochem Behav, 50(2), 163-169.
Tshitoyan, V., Dagdelen, J., Weston, L., Dunn, A., Rong, Z., Kononova, O., Persson, K. A., Ceder, G., & Jain, A. (2019). Unsupervised word embeddings capture latent knowledge from materials science literature. Nature, 571(7763), 95-98.
Welter, J., Kavanagh, P., Meyer, M. R., & Maurer, H. H. (2015). Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques. Anal Bioanal Chem, 407(5), 1371-1388.
Wohlfarth, A., Roman, M., Andersson, M., Kugelberg, F. C., Diao, X., Carlier, J., Eriksson, C., Wu, X., Konradsson, P., Josefsson, M., Huestis, M. A., & Kronstrand, R. (2017). 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry. Drug Test Anal, 9(5), 680-698.
Wood, D. M., & Dargan, P. I. (2012). Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin Toxicol (Phila), 50(8), 727-732.